Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone

Amylyx Pharmaceuticals (AMLX) shares are in focus after the company reported that the final participant has been randomized and dosed in LUCIDITY, its pivotal Phase 3 trial of avexitide for post-bariatric hypoglycemia. See our latest analysis for Amylyx Pharmaceuticals. The latest trial milestone arrives as momentum in Amylyx Pharmaceuticals' share price has been building, with a 7 day share price return of 23.98% and a 90 day share price return of 39.02%, set against a very large 1 year...
NYSE:MMS
NYSE:MMSProfessional Services

Assessing Maximus (MMS) Valuation After Recent Share Price Weakness And Undervaluation Debate

Maximus stock overview Maximus (MMS) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past month and past 3 months. This has prompted closer scrutiny of its current valuation and fundamentals. See our latest analysis for Maximus. At a share price of $63.72, Maximus has seen a 30 day share price return of 18.32% and a 90 day share price return decline of 28.50%, while the 1 year total shareholder return sits at a decline...
TSE:8850
TSE:8850Real Estate

Is Starts (TSE:8850) Elevating Legal Oversight To Reframe Its Governance-Driven Investment Story?

In April 2026, Starts Corporation Inc. appointed its legal affairs chief, Takashi Kubota, as an executive officer, following a board meeting held on 2 April 2026 to consider this leadership change. This promotion highlights an increased emphasis on governance, compliance, and legal risk management, which can be especially important for real estate and service companies. Next, we will explore how Kubota’s expanded role in legal oversight could influence Starts Corporation’s investment...
TSX:GMIN
TSX:GMINMetals and Mining

G Mining Ventures (TSX:GMIN) Is Up 15.5% After Surging 2025 Earnings – Has The Bull Case Changed?

G Mining Ventures Corp. has released its full-year 2025 results, reporting sales of US$580.67 million and net income of US$287.86 million, with basic earnings per share from continuing operations of US$1.27. These results show very large year-on-year increases in both revenue and profitability, indicating a major shift in the company’s operating scale and earnings power. We’ll now explore how this sharp step-up in annual sales and net income may reshape G Mining Ventures’ broader investment...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

A Look At Agilysys (AGYS) Valuation After Recent Share Price Volatility

Context for Agilysys (AGYS) investors Agilysys (AGYS) has drawn fresh attention after recent share price swings, with the stock showing mixed near term performance and a sharper decline over the past 3 months from a last close of $71.49. See our latest analysis for Agilysys. The recent pullback, including a 39% 3 month share price return decline and 38% year to date share price return decline from $71.49, contrasts with a 1 year total shareholder return of 6.4%, suggesting fading short term...
NYSE:MCO
NYSE:MCOCapital Markets

Assessing Moody’s (MCO) Valuation After Earnings Beat Guidance Raise And Dividend Increase

Moody's (MCO) is back in focus after quarterly earnings topped analyst expectations, with contributions from both its ratings and analytics divisions, along with higher full year earnings guidance and an increased quarterly dividend. See our latest analysis for Moody's. Despite a softer 30 day share price return of 5.91% and a 90 day share price return of 16.66%, Moody's 1 year total shareholder return of 12.47% and 3 year total shareholder return of 53.95% point to momentum that has built...
NYSE:NE
NYSE:NEEnergy Services

What Noble (NE)'s Fully Automated Offshore Guyana Well Means For Shareholders

Noble recently participated in a project with Halliburton, ExxonMobil and the Wells Alliance Guyana team that achieved the first fully automated geological well placement with complete rig automation in offshore Guyana, integrating automated subsurface interpretation, well placement and real-time hydraulics. This milestone in Noble’s offshore operations highlights its role in advancing drilling automation, potentially reinforcing its positioning as a high-tech contractor in complex deepwater...
NYSE:CLX
NYSE:CLXHousehold Products

A Look At Clorox (CLX) Valuation After Softer Earnings And Cautious Growth Outlook

Fresh analyst commentary and Clorox (CLX) management remarks have pushed the stock back into focus as investors weigh cost inflation, trade down risks, currency headwinds, and a softer outlook for category growth. See our latest analysis for Clorox. At a share price of $104.89, Clorox has seen a 3.71% 1 day share price return and a 2.41% 7 day share price return. However, its 1 year total shareholder return of 21.39% and 5 year total shareholder return of 35.24% highlight fading longer term...
NYSE:EPAM
NYSE:EPAMIT

Is EPAM Systems (EPAM) Share Price Misaligned With Its Cash Flow Outlook?

If you are looking at EPAM Systems and wondering whether the current share price reflects its true worth, the valuation picture is more nuanced than a quick glance at the chart suggests. The stock last closed at US$137.02, with a 0.6% move over the past week, a 6.1% decline over 30 days, and returns of 31.6% decline year to date and 5.5% decline over the past year, following even steeper 3-year and 5-year declines of 52.9% and 67.7% respectively. These moves have kept EPAM on the radar for...
NYSE:MDT
NYSE:MDTMedical Equipment

If You Believe In AI Healthcare Then These Three Stocks Could Shape Your Next Cycle

AI is starting to reshape how healthcare is delivered, from spotting disease earlier to tailoring treatments and cutting wasted time in hospitals, just as energy driven inflation and higher yields keep pressure on costs worldwide. For investors, that mix of structural healthcare demand and AI driven efficiency tools offers exposure to a theme that is less tied to short term swings in consumer spending or manufacturing cycles. This article walks through 3 stocks from our Transformative AI...
TSX:ORE
TSX:OREMetals and Mining

Why Orezone Gold (TSX:ORE) Is Up 9.3% After Boosting Its 2026 Production Guidance – And What's Next

In March 2026, Orezone Gold Corporation reported its fourth-quarter and full-year 2025 results, producing 30,407 ounces of gold in Q4 and 110,014 ounces for the year, slightly below the 118,746 ounces recorded in 2024. At the same time, Orezone issued a much higher 2026 production guidance of 160,000 to 180,000 ounces, highlighting management’s confidence in operational progress despite the softer 2025 output. We’ll now examine how this higher 2026 production guidance reshapes Orezone Gold’s...
NYSE:ABBV
NYSE:ABBVBiotechs

Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness

What AbbVie’s Recent Share Performance Signals for Investors AbbVie (ABBV) has recently seen a one-month return of about a 10% decline and a past three-month return of roughly a 7% decline, even as its one-year total return stands at about 14%. See our latest analysis for AbbVie. At a share price of US$206.69, AbbVie’s recent share price return has been weak over the past month and quarter, while its multi year total shareholder returns remain clearly positive. This suggests momentum has...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

A Look At Sezzle (SEZL) Valuation After Fresh Analyst Outperform Rating

Analyst coverage sparks fresh interest in Sezzle A new research note initiating coverage of Sezzle (SEZL) with an Outperform rating has pushed the stock into focus, as investors weigh that positive view against recent insider selling and earnings quality concerns. See our latest analysis for Sezzle. After the fresh Outperform rating, Sezzle’s recent 7.92% 1 day and 13.30% 7 day share price returns stand in contrast to its 6.34% 30 day share price decline, while a 125.16% 1 year total...
NYSE:SCI
NYSE:SCIConsumer Services

Does Stagnant Volumes And Weaker Returns Change The Bull Case For Service Corporation International (SCI)?

Recent analysis of past performance shows that Service Corporation International has not increased the number of funeral services performed over the last two years, while also reporting weaker free cash flow margins and a declining return on invested capital compared with sector expectations. This combination of stagnant service volumes and deteriorating profitability metrics suggests the company may be contending with demand constraints and limited high-return reinvestment...
NYSE:HP
NYSE:HPEnergy Services

Is Utica Square Debt Retirement Reshaping the Investment Case for Helmerich & Payne (HP)?

Helmerich & Payne has completed the sale of Tulsa’s Utica Square retail center, with after-tax proceeds exceeding its US$100 million divestiture target and earmarked largely to retire the company’s remaining term loan as part of a balance sheet-focused portfolio review. The move marks a significant shift away from non-core real estate and frees up financial capacity that can be redeployed toward Helmerich & Payne’s core drilling and technology operations following its capital-intensive KCA...
NYSE:AYI
NYSE:AYIElectrical

A Look At Acuity Brands (AYI) Valuation After Mixed Q2 2026 Earnings And Segment Trends

Acuity (AYI) is back in focus after its second quarter 2026 earnings, where adjusted earnings per share came in ahead of expectations while revenue lagged forecasts, highlighting contrasting trends across its Lighting and Intelligent Spaces businesses. See our latest analysis for Acuity. The share price reaction has been mixed, with a 1 day share price return of 1.06% after earnings but a 90 day share price return representing a 28.55% decline. However, the 3 year total shareholder return of...
NasdaqGS:XERS
NasdaqGS:XERSPharmaceuticals

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Q4 2025 Earnings Beat

Xeris Biopharma Holdings (XERS) drew fresh investor attention after reporting fourth quarter 2025 earnings per share of US$0.06 on revenue of US$85.8 million, both above prior projections and supported by a reiteration of positive analyst views. See our latest analysis for Xeris Biopharma Holdings. At a share price of US$6.05, Xeris Biopharma’s recent 8.04% 7 day share price return and 4.13% 30 day share price return contrast with a 17.69% decline year to date. At the same time, the 37.19% 1...
NYSE:OLN
NYSE:OLNChemicals

Will Wells Fargo’s Margin-Focused Upgrade Shift Olin’s (OLN) Cost Advantage and Pricing Power Narrative?

Olin Corporation recently received an upgrade from Wells Fargo, with the firm citing expectations of stronger margins in its electrochemical operations supported by higher caustic soda prices and stable North American natural gas costs. This shift in analyst view highlights how Olin’s earnings outlook is increasingly being tied to both its cost position and evolving global chemical pricing shaped by geopolitical tensions. We’ll now examine how this margin-focused upgrade from Wells Fargo...
NYSE:AIZ
NYSE:AIZInsurance

How Assurant’s Home Warranty Push and Profitable Streak Will Impact Assurant (AIZ) Investors

Assurant recently reported its ninth consecutive year of profitable growth, highlighted by strong Q4 2025 earnings, record mobile trade-in activity, and the launch of Assurant Home Warranty through a partnership with Compass International Holdings, expanding its reach in the real estate channel. These developments underline how Assurant’s diversified protection offerings and new distribution partnerships are reinforcing its position across connected devices, housing, and broader lifestyle...